U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684274) titled 'Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics' on June 12.
Brief Summary: Study on Early Screening of Myeloma Based on Liquid Biopsy cfDNA Fragmentomics Technology. This study aims to construct and validate a set of machine learning models for the early screening of myeloma tailored to the Chinese population, based on plasma cfDNA fragmentomics features, to effectively distinguish myeloma patients from healthy individuals.
Study Start Date: June 13
Study Type: OBSERVATIONAL
Condition:
Multiple Myeloma (MM)
Smoldering Multiple Myeloma (SMM)
MGUS
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Th...